06/13/2026
Don’t miss our oral presentation and two posters today at . Presentation details:
𝘖𝘳𝘢𝘭 𝘗𝘳𝘦𝘴𝘦𝘯𝘵𝘢𝘵𝘪𝘰𝘯
Presentation Title: Ersodetug (RZ358) in Congenital Hyperinsulinism: Top-Line Results from a Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study (sunRIZE)
Poster Number: ORF10-06
Time: 2:30 PM CDT
Location: Room W183BC
𝘗𝘰𝘴𝘵𝘦𝘳 𝘗𝘳𝘦𝘴𝘦𝘯𝘵𝘢𝘵𝘪𝘰𝘯𝘴
Presentation Title: A Case Series on the Compassionate Use of Ersodetug, an Insulin Receptor Modulating Antibody, in Patients with Refractory Hypoglycemia Due to Malignant Insulin-Secreting Tumors
Poster Number: SAT-087
Time: 12:15 PM CDT
Location: Poster Floor
Presentation Title: Association of Early-Life Hypoglycemia with Later Neurological Outcomes in Congenital Hyperinsulinism: A US Claims-Based Study
Poster Number: SAT-221
Time: 12:15 PM CDT
Location: Poster Floor
Join us to learn more and connect with our team at booth #4826 afterward for discussion and questions.
ENDO details: https://bit.ly/4uo6NEN